Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates - Wikidata - wikimedia - TriplyDB

Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates

Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates

http://www.wikidata.org/entity/Q33713075

about

Lentiviral vectors in gene therapy: their current status and future potential Development of an inducible caspase-9 safety switch for pluripotent stem cell-based therapies Thymidine kinase suicide gene-mediated ganciclovir ablation of autologous gene-modified rhesus hematopoiesis.Induced pluripotent stem cells for regenerative cardiovascular therapies and biomedical discovery.Lentiviral vectors for induction of self-differentiation and conditional ablation of dendritic cells.Improved Hepatocyte Engraftment After Portal Vein Occlusion in LDL Receptor-Deficient WHHL Rabbits and Lentiviral-Mediated Phenotypic Correction In Vitro Recent developments in doping testing for erythropoietin.Countering hepatitis B virus infection using RNAi: how far are we from the clinic?Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future.Recent advances in developing nucleic acid-based HBV therapy.Conditional Cytotoxic Anti-HIV Gene Therapy for Selectable Cell Modification.Rhesus monkeys for a nonhuman primate model of cytomegalovirus infections.Elimination of proliferating cells from CNS grafts using a Ki67 promoter-driven thymidine kinase.Sustained inhibition of hepatitis B virus replication in vivo using RNAi-activating lentiviruses.

P2860

Q24629462-CBFBA5D6-B26E-4572-A456-39BD28CB7AC7 Q34044181-EA8739B4-AF28-410A-B840-32C9968C4564 Q34295186-E997BF7A-F619-40F3-AC5C-727D328EA901 Q35028209-87BDD2CA-035C-4918-88F4-07FF4AD8113F Q35161543-BB013C42-F7FE-48DF-963D-71EB55AE82DB Q35917970-CF7B3AFA-4D49-4618-8223-3948EF410C4E Q37884431-EFC0734F-4948-4458-9369-5117BE1E1E11 Q37931159-605DB1A8-B946-40EC-ACF7-473BF6C55198 Q38029405-C2BE40F0-28D2-49DE-9673-E51F0B51F910 Q38160538-BE043401-38D0-4F14-9A09-16C0F4B5A3B4 Q38800411-630298A3-94CD-47F1-AA4A-A983015D66D6 Q40059344-750ACFF9-06C3-445F-987A-125949E998BF Q40418970-E8F2FC2D-A742-48F3-83EE-610234D2F44D Q41691498-34136CB6-DDF7-44F3-ABFD-8483911C1E50

P2860

Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates

http://www.wikidata.org/entity/Q33713075

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Biosafety in ex vivo gene ther ...... patocytes in nonhuman primates

@ast

Biosafety in ex vivo gene ther ...... patocytes in nonhuman primates

@en

type

label

Biosafety in ex vivo gene ther ...... patocytes in nonhuman primates

@ast

Biosafety in ex vivo gene ther ...... patocytes in nonhuman primates

@en

prefLabel

Biosafety in ex vivo gene ther ...... patocytes in nonhuman primates

@ast

Biosafety in ex vivo gene ther ...... patocytes in nonhuman primates

@en

P1433

Q33713075-0691419C-5206-46F5-910E-A35B02071317

P1476

Q33713075-FA8FC442-75BE-419D-91DA-141384937196

P2093

Q33713075-0FF8FB71-CC88-4C20-ABA8-20BC99121006

Q33713075-385AC45B-E8B0-41D5-8271-9AE08E75CDC8

Q33713075-3D108977-BB61-4FC9-9666-B06260CC253D

Q33713075-7F9097A2-70A7-4F43-BD23-6E6C855ACBF2

Q33713075-8F4E6B01-2712-4A07-AB80-DD181EC5135A

Q33713075-A13818A3-0F57-401A-AFD6-E4227C66190A

Q33713075-D431B1C0-0097-4C9F-9E99-AD15A3B2AA68

Q33713075-F864A796-A7FC-4571-9753-AC5A3843FDF7

Q33713075-FDBB887C-724C-41BB-96BD-ACBECFE03184

P2860

Q33713075-0E9BAA7A-D283-419B-9C85-7EB3F076BC13

Q33713075-1AD27D3D-29ED-4ECA-BC96-9454513398AC

Q33713075-21CFC022-ED1F-40FA-8D94-21A49D5F2DDB

Q33713075-2299CF19-A2D9-415B-986E-F49CEAF91C78

Q33713075-410CFBFC-5C77-440B-BBA0-DDC57DB40EC2

Q33713075-424A4725-8BE3-478A-81CC-21329E72CBB4

Q33713075-45A43414-5E57-4774-8084-444CB705A0D4

Q33713075-53DE0378-1497-428C-AFF0-DE0552B59D35

Q33713075-54D5001B-3EE5-4AFB-8892-CB28B979F3BD

Q33713075-5E17F059-A8CA-491C-A284-36C6BAC3C17E

P304

Q33713075-5FD5CB65-136B-4544-8118-BA92860C80A6

P31

Q33713075-C198E427-9924-4236-B481-BA3A61815F58

P356

Q33713075-ECD287D3-8710-4D33-B91B-AB0C2146973E

P433

Q33713075-FC261E7D-E505-47D2-85E7-12B8DECCB197

P478

Q33713075-56F4B8CE-674E-424A-8F98-5650389D6C65

P577

Q33713075-D9706153-5997-4081-8BEF-E940E991654A

P5875

Q33713075-851C568D-7BD3-4CD4-BDEB-1311657A41C9

P698

Q33713075-728CD39C-A199-4749-B085-D30158ADBD0A

P921

Q33713075-13C7D3B9-FF18-48CF-8763-FBB9ADC590F2

P932

Q33713075-C07B912D-E806-437B-8C03-0E5FFC1DAB94

P356

P1433

Molecular Therapy

P1476

Biosafety in ex vivo gene ther ...... patocytes in nonhuman primates

@en

P2093

Barbara E Wildhaber

http://www.w3.org/2001/XMLSchema#string

Caty Jond

http://www.w3.org/2001/XMLSchema#string

Christophe Chardot

http://www.w3.org/2001/XMLSchema#string

Didier Trono

http://www.w3.org/2001/XMLSchema#string

Françoise Lasne

http://www.w3.org/2001/XMLSchema#string

Jacques Birraux

http://www.w3.org/2001/XMLSchema#string

Olivier Menzel

http://www.w3.org/2001/XMLSchema#string

Tuan H Nguyen

http://www.w3.org/2001/XMLSchema#string

Walid Habre

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration

A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

Engraftment of autologous retrovirally transduced hepatocytes after intraportal transplantation into nonhuman primates: implication for ex vivo gene therapy.

Efficient hepatocyte engraftment in a nonhuman primate model after partial portal vein embolization.

In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors.

Influence of the bystander effect on HSV-tk/GCV gene therapy. A review.

Hepatocyte transplantation for inborn errors of metabolism.

Neuroinvasion of fluorescein-positive monocytes in acute simian immunodeficiency virus infection.

P304

1754-1760

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2009.143

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26332074

http://www.w3.org/2001/XMLSchema#string

P698

19568222

http://www.w3.org/2001/XMLSchema#string

P921

P932

2835009

http://www.w3.org/2001/XMLSchema#string